G 2/88 provides legal assessment for novelty of a non-medical use claim. G 2/88 allows acknowledging novelty of a non-medical use claim of an old compound for a particular pur...
Continue reading
European Patent EP 2 825 558 concerns a combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer. The claim was supported by Phase III AURELIA c...
Continue reading
On the issue of the potential continuation of EPO appeal proceedings by an intervener the questions for referral on which we already reported
Continue reading
All articles
Cyprumed GmbH and Merck & Co., Inc. have entered a Non-Exclusive License and Option Agreement to develop oral formulations of peptides using Cyprumed’s drug delivery technology. MSD gains global non-exclusive rights...
Continue reading
The market analysis by Managing IP and the IP STARS ranking 2024 confirm this: The German market for intellectual property remains dynamic and highly competitive. Especially in the field of patent law, numerous law firms were able to maintain and expand their leading positio...
Continue reading
A European Patent Office board of appeal said in a ruling published on March 10th that Roche Diagnostics GmbH proved Verinata Health Inc.'s blueprint lacks an inventive step over an earlier international patent application setting out a similar way of testing "free-floating ...
Continue reading
Maiwald in the press
We congratulate Dr. Anna Closs on passing the German patent attorney examination!
Continue reading
Effective January 1, 2025, Maiwald, one of Germany's leading intellectual property law firms, appointed two new Counsel, Dr. Lukas Delvos and Dr. Jian Sun. Lukas Delvos until ...
Continue reading
Staff News
This article covers the most recent developments regarding the European Research Exemption, which permits the use of patented inventions for research purposes, as well as the ...
Continue reading
The jurisdictional reach of the Unified Patent Court (UPC) was a widely and controversially discussed topic from the outset. Some practitioners took the view that the UPC also...
Continue reading
All publications
We are delighted that our colleague Dr. Marco Stie...
Continue reading
Using a two-stage survey and evaluation process that takes into account recommendations from lawyers, business and corporate clients, Statista, together with the business maga...
Continue reading
We are proud to share that Chambers & Partners has ranked Maiwald in their inaugural 2025 Germany edition for
Continue reading
All awards
Tue.
20
The Oblon and Maiwald firms are pleased to invite you to a complimentary joint international symposium on: U.S. and European Patent Practice: Important Aspects for Practitioners At the 2025 joint symposium, we will together examine selected current aspects of protecting innovation...
Continue reading
Sat.
17
The International Trademark Association's (INTA) Annual Meeting took place in San Diego from May 17 to 21 this year. Maiwald was among the many companies and law firms in attendance, represented by Susanna Heurung,
Continue reading
Thu.
15
Patent law news: EPO case law, software and UPC (Lectures will be held in German) On May 15, we had the pleasure of hosting another Maiwald seminar in our office. Thank you to the speakers and everyone involved for making this an interesting afternoon and ensuring the event ran smoothly.
Continue reading
Tue.
13
This year's Spring Meeting of the American Intellectual Property Law Association (AIPLA) took place in Minneapolis from May 13-15, 2025. The event brings together international experts from the field of intellectual property to discuss current developments at the interface of law, technology and innovation. Maiwald was r...
Continue reading
All events